144 ·Filed Apr 17, 2026

MLYS

Mineralys Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001964306-26-000208
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, non-material sale by an officer; no immediate trading signal. Monitor for changes in volume or frequency, but current pattern suggests planned, periodic selling rather than a shift in sentiment.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
MLYS ▼ -9.18% at T+60d
NEUTRAL call ✗ call lost -9.18% · α vs SPY -15.96% · entry $30.07 → $27.31
Entry anchored
Apr 17, 03:59 PM ET
via exchange tick
T+1d
-4.29%
call -4.29% · α -3.64%
$28.78
settled 6mo ago
T+5d
-10.24%
call -10.24% · α -11.16%
$26.99
settled 5mo ago
T+20d
-12.24%
call -12.24% · α -16.44%
$26.39
settled 5mo ago
T+60d
-9.18%
call -9.18% · α -15.96%
$27.31
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

David Rodman, an officer of Mineralys Therapeutics, filed a Form 144 notifying intent to sell 416 shares of common stock, acquired via exercise of employee stock options. This is a routine, small-scale transaction consistent with prior regular sales.

Key Facts

  • Reporting person: David Rodman, Officer
  • Number of shares proposed for sale: 416
  • Nature of shares: Acquired through exercise of employee stock options
  • Method: Broker-assisted cashless exercise
  • Filing date: April 17, 2026
  • Recent pattern: Part of ongoing, regular small sales — 13 similar transactions in the past 6 months

Financial Impact

Approximately $13,000 (based on 13,033.28 from prior transaction on 04/17/2026)

insider ownershipshare count

Risk Factors

  • Minimal near-term selling pressure from this filing
  • Potential perception of lack of confidence if pattern accelerates, though current pace is normal

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001964306-26-000208
Document: 0001964306-26-000208-index.html0001964306-26-000208
Document: 0001964306-26-000208.txt0001964306-26-000208
22 reports for MLYS
Performance horizon
67% Hit rate 4 of 6 directional calls best @ T+20▲ +20.97%Jun 11, 2026
Filters
Rows
Reports for MLYS — sortable, filterable
TypeNow
Aug 12, 2026
7w ago
3
NEUTRAL ★ 2/10
$26.09 $28.20▲ +8.09%▲ +9.83%$23.56 (−9.70%)
Jul 23, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.71 $25.65▼ −3.97%▼ −7.59%$23.56 (−11.79%)
Jul 21, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$27.52 $26.61▼ −3.31%▼ −5.87%$23.56 (−14.39%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$27.08 $26.09▼ −3.66%▼ −7.27%$23.56 (−13.00%)
Jun 30, 2026
13w ago
144
NEUTRAL ★ 3/10
$26.89 $26.35▼ −2.01%▲ +0.18%$23.56 (−12.38%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 3/10
$26.88 $26.71▼ −0.63%▼ −0.35%$23.56 (−12.35%)
Jun 18, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.63 $27.08▲ +9.95%▲ +9.41%$23.56 (−4.34%)
Jun 17, 2026
15w ago
144
NEUTRAL ★ 2/10
$24.63 $27.08▲ +9.95%▲ +9.41%$23.56 (−4.34%)
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 6/10
$23.94 $28.96▲ +20.97%▲ +19.08%$23.56 (−1.59%)
Jun 3, 2026
17w ago
8-K
MIXED ★ 7/10
$25.06 $27.69▲ +10.49%▲ +11.49%$23.56 (−5.99%)
Showing 10 of 22

US Market Status

Market Open — Closes in 3h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access